Table 1

Patient characteristics at diagnosis.

Age at diagnosis

Years


Mean (range)

69.2 (45 - 88)


Age at diagnosis

Number of Patients

Percent of Patients


45-49

1

0.3


50-54

7

2.3


55-59

23

7.6


60-64

35

11.5


65-70

54

17.8


70-74

80

26.3


75-79

54

17.8


80-84

36

11.8


85-88

14

4.6


PSA level at diagnosis

ng/mL


Mean (range)

6.08 (0.7 to 27.7)


Median

5.8


PSA level at diagnosis

Number of Patients

Percent of Patients


<4 ng/mL

59

19.4


4-10 ng/mL

203

66.8


>10-20 ng/mL

40

13.2


>20 ng/mL

2

0.7


Clinical Stage

Number of Patients

Percent of Patients


T1cN0 M0

280

92.1


T2aN0 M0

24

7.9


Gleason Score

Number of Patients

Percent of Patients


= 6

222

73


= 7

70

23


> 8

12

4


Hormone Treatment

Number of Patients

Percent of Patients


No

247

81.3


Yes

57

18.8


Risk Assessment: Criteria

Number of Patients

Percent of Patients


Low Risk: Gleason Score ≤ 6 and PSA ≤ 10 ng/ml.

211

69.4


Intermediate Risk: Gleason = 7 or PSA>10 and PSA < 20

81

26.6


High Risk: Gleason ≥ 8 or PSA > 20

12

3.9


Katz et al. BMC Urology 2010 10:1   doi:10.1186/1471-2490-10-1

Open Data